SOLARA ACTIVE PHARMA SCIENCES LIMITED — Investor Relations & Filings
Solara Active Pharma Sciences Limited is a customer-centric organization specializing in the development and manufacturing of active pharmaceutical ingredients (APIs). The company offers a diverse portfolio of high-quality products across therapeutic categories such as pain management, central nervous system, and anti-infectives. It operates several manufacturing sites and research centers that comply with global regulatory standards, including the USFDA and EUGMP. Beyond its commercial API catalog, the company provides comprehensive contract development and manufacturing organization (CDMO) services, assisting partners from the initial research phase to large-scale production. Known for its significant production capacity in key molecules like Ibuprofen, the company focuses on delivering complex and niche APIs to global markets through advanced technical expertise and a commitment to quality excellence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Press Release | 2025-11-19 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2025-11-11 | English | |
| Copy of Newspaper Publication | 2025-11-06 | English | |
| Monitoring Agency Report | 2025-11-06 | English | |
| Outcome of Board Meeting | 2025-11-06 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2025-11-05 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 42238293 | Press Release | 2025-11-19 | English | ||
| 42328891 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-11-11 | English | ||
| 42230304 | Copy of Newspaper Publication | 2025-11-06 | English | ||
| 42231712 | Monitoring Agency Report | 2025-11-06 | English | ||
| 42247230 | Outcome of Board Meeting | 2025-11-06 | English | ||
| 42251502 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-11-05 | English | ||
| 42256586 | General Updates | 2025-11-05 | English | ||
| 42257034 | ESOP/ESOS/ESPS | 2025-11-05 | English | ||
| 42257469 | Statement of deviation(s) or variation(s) under Reg. 32 | 2025-11-05 | English | ||
| 42257652 | ESOP/ESOS/ESPS | 2025-11-05 | English | ||
| 42257765 | General Updates | 2025-11-05 | English | ||
| 42258169 | Press Release | 2025-11-05 | English | ||
| 42258241 | Cessation | 2025-11-05 | English | ||
| 42258641 | Outcome of Board Meeting | 2025-11-05 | English | ||
| 42229496 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-10-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SOLARA ACTIVE PHARMA SCIENCES LIMITED via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61842/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61842 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61842 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61842 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61842}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SOLARA ACTIVE PHARMA SCIENCES LIMITED (id: 61842)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.